REMINDER: ORLive Presents: Access to Surgical Intervention for Metabolic Syndrome and Other Diseases

Webcast: From Minneapolis, MN: June 17, 2008 at 4:00 PM CDT (21:00 UTC)

MINNEAPOLIS, MN–(EMWNews – July 17, 2008) – On Tuesday, June 17, 2008, at 4:00 pm CDT,

EMWNews“>ORLive.com

will broadcast a panel discussion entitled, “Access to Surgical

Intervention for Metabolic Syndrome and Other Diseases.” Dr. Henry

Buchwald, Professor of Surgery, University of Minnesota, Minneapolis,

Minnesota, will serve as moderator. The panel will include Dr. Neil

Hutcher, Commonwealth Surgeons, St Mary’s Bon Secours Hospital, Richmond,

VA., Dr. Scott A. Shikora, Professor of Surgery, Tufts University School of

Medicine, Chief, General, Bariatric and Minimally Invasive Surgery, Tufts

Medical Center, Boston, Massachusetts, and Walter Lindstrom, Jr., Esq.,

Obesity Law and Advocacy Center, Chula Vista, CA., a leading advocate for

the rights of persons suffering from EMWNews“>obesity. Join this leadership

panel as they discuss the challenges of access to surgical intervention for

the resolution of metabolic syndrome and other

diseases and suggestions for improvement.

Questions from Healthcare professionals and the general public can be sent

to Dr. Buchwald, Dr. Hutcher, Dr. Shikora, and Mr. Lindstrom up to seven

days following the broadcast. The panelists will also address questions on

June 18, 2008 at the American Society for Metabolic and

Bariatric Surgery Annual meeting in Washington, D.C.

Obesity is associated with multiple co-morbidities, including diabetes

mellitus, hypertension,

hypercholesterolemia, obstructive sleep apnea, osteoarthritis, gastroesophageal

reflux disease (GERD), asthma, and depression. These co-morbidities are

responsible for more than 2.5 million deaths per year worldwide. Surgical

weight loss has been shown to improve if not resolve many of these

co-morbidities.

About Synovis Life Technologies

Synovis Life Technologies, Inc. (NASDAQ: SYNO), based in St. Paul, Minn.,

is a diversified medical device company engaged in developing,

manufacturing, and bringing to market medical devices for the surgical and

interventional treatment of disease.

To learn more and view a program preview visit OR-Live

VNR: OR-Live.com